|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM330721127 |
| 003 |
DE-627 |
| 005 |
20231225211906.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2021 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2021.108854
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1102.xml
|
| 035 |
|
|
|a (DE-627)NLM330721127
|
| 035 |
|
|
|a (NLM)34530137
|
| 035 |
|
|
|a (PII)S1521-6616(21)00191-1
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Gazzito Del Padre, Talita C
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Distribution of monocytes subpopulations in the peripheral blood from patients with Behçet's disease - Impact of disease status and colchicine use
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 09.11.2021
|
| 500 |
|
|
|a Date Revised 09.11.2021
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2021 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a The innate immune response has a predominant role in Behçet's disease (BD) pathogenesis, but few studies have assessed monocytes in BD. This study aims to evaluate the profile of monocytes subsets in the peripheral blood of BD patients and healthy controls (HC). Monocytes subsets were identified as classical (CD14+CD16-), intermediate (CD14+CD16dim), and non-classical (CD14dimCD16high) subsets. Patients with BD presented a lower number of total monocytes (p = 0.020) and a lower number (p < 0.0001) of circulating classical monocytes than HC. In contrast, the number of intermediate monocytes was higher in BD patients than HC (p < 0.0001). In BD patients, no associations were observed with the severity of clinical manifestations or therapy. Colchicine was associated with a higher number of non-classical monocytes (p = 0.035). In conclusion, BD patients present an altered distribution of monocytes subsets with a reduction of classical and an increase of intermediate subsets
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a Behçet syndrome
|
| 650 |
|
4 |
|a Disease activity
|
| 650 |
|
4 |
|a Innate immunity
|
| 650 |
|
4 |
|a Monocytes
|
| 650 |
|
4 |
|a Systemic vasculitis
|
| 650 |
|
7 |
|a Tubulin Modulators
|2 NLM
|
| 650 |
|
7 |
|a Colchicine
|2 NLM
|
| 650 |
|
7 |
|a SML2Y3J35T
|2 NLM
|
| 700 |
1 |
|
|a Belem, Joice Moraes F M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a de Aguiar, Mariana Freitas
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Torquato, Heron Fernandes Vieira
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Paredes-Gamero, Edgar Julian
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Abdulahad, Wayel H
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Brouwer, Elisabeth
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a de Souza, Alexandre W S
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 231(2021) vom: 01. Okt., Seite 108854
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:231
|g year:2021
|g day:01
|g month:10
|g pages:108854
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2021.108854
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 231
|j 2021
|b 01
|c 10
|h 108854
|